Profit

Aurobindo sets eyes on pharmaceutical API CRAMS biz

Aurobindo sets eyes on API CRAMS biz

By Natalie Morrison

Aurobindo has announced long term plans to steer away from its generics making business in a bid to focus on long term API manufacturing partnerships.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers